Progressive Supranuclear Palsy (PSP)

Definition

Progressive supranuclear palsy (PSP) - also known as Steele-Richardson-Olszewski syndrome - is a rare degenerative neurological disease - only about 4-5 percent as common as Parkinson's disease. The peak age for contracting this disease is in the mid-60's and it appears to affect men more often than women.

PSP is characterized by symptoms similar to Parkinson's disease such as unsteady gait, unexplained falling, stiff movements, and mild dementia plus other symptoms not normally a part of Parkinson's disease icluding problems with the voluntary movement of the eyes.

PSP is a disorder that is often misdiagnosed. Some of the symptoms used to identify the disease, including the eye movement problems, do not appear until the patient is several years into the progression of the disease. For this reason, PSP is often diagnosed as some other illness (such as Parkinson's or Alzheimer's) in its earlier stages.

History of Progressive Supranuclear Palsy (PSP)

PSP was first observed by Dr J. Clifford Richardson during the 1950s in Toronto. He recognised a few patients who exhibited an unusual neurological syndrome of supranuclear ophthalmoplegia [nerve problems that affect the eye muscles], pseudobulbar palsy [nerve problems that affect the muscles of the palate, tongue and throat, causing problems with swallowing, gagging and speech], dystonia [problems with the muscles], rigidity of the limbs, dementia and other less typical symptoms, and invited Dr John Steele and Dr J. Olszewski to study the pathological changes in the central nervous system.

The results of this study were published in a medical journal in 1964. This resulted in the disease also being known as Steele-Richardson-Olszewksi syndrome which is the term still used in much of the world outside the United States.

PSP wasn't a new disease, it was just so rare that no one had determined it was it's own condition and not a variation of Parkinson's disease.

The researchers found that neuronal cell loss, neurofibrillary degeneration and gliosis [conditions in which the nerve fibres in the brain can become dense and tangled] were extensive in the brain stem, diencephalic and cerebellar nuclei. Damage to pontomedullary reticular nuclei was also likely. Changes in the metabolism of glucose were found in the prefrontal, premotor ungulate cortex and thalamus parts of the brain.

Many parts of the brain are affected including the brainstem, the basal ganglia, and the cerebellum. The brainstem is located at the top of the spinal cord. It controls the most basic functions needed for survival--the involuntary (unwilled) movements such as breathing, blood pressure, and heart rate. The brainstem has three parts: the medulla oblongata, the pons, and the midbrain. The parts affected by PSP are the pons, which controls facial nerves and the muscles that turn the eye outward, and the midbrain, the visual center. The basal ganglia are islands of nerve cells located deep within the brain. They are involved in the initiation of voluntary (willed) movement and control of emotion. Damage to the basal ganglia causes muscle stiffness (spasticity) and tremors. The cerebellum is located at the base of the skull. It controls balance and muscle coordination.

What are the First Symptoms of PSP?

The first symptoms usually begin between ages 50 and 70 (peaking in the early sixties), with a range from the early forties to the late eighties and is more common in men than in women.

The most common first symptom usually is loss of balance while walking or experiencing several unexplained falls over a year. Patients may develop some stiffness and walking awkwardness and be incorrectly diagnosed as having Parkinson's Disease. Patients however rarely develop the resting tremor and stooped posture characteristic of Parkinsonism. Falling can also cause broken bones and fractures that are difficult to treat.

Other common early symptoms may be changes in personality and forgetfulness. This can take the form of a loss of interest in ordinary pleasurable activities or increased irritability and cantankerousness. These mental changes are often misinterpreted as depression. They would be more correctly diagnosed as being symptoms of patient apathy.

Less common early symptoms are trouble with eyesight, slurring of speech, difficuly driving a car and having unexplained accidents.

The Development of Additional Problems and Symptoms

As it can happen with Multiple Sclerosis and other diseases, PSP causes loss of the myelin sheath (the covering of the nerve cell that speeds nerve impulse conduction) in some nerves and destruction of the entire nerve in other areas. There is a palsy or paralysis, that slowly gets worse as the disease progresses.

Additional symptoms develop over time due to the increased damage to brain tissue caused by the disease. It is this development of new symptoms that further defines the condition and often leads to a change in diagnosis from some other disease to PSP.

Gaze palsy (vision)

This presense of this symptom (technically known as ophthalmoparesis and uncommon with Parkinson's and Alzheimer's diseases) along with the development of walking difficulties are used as primary indications in the diagnosis of PSP. In most cases the walking problems occur first followed in 3 to 5 years by the problems with the eyes.

Vision is controlled by groups of cells called nuclei in the brainstem. In PSP, the nuclei continue to function, but the mechanisms that control the nuclei are destroyed. The term supranuclear means that the damage is done above (supra) the nuclei.

With gaze palsy there is an impaired ability to voluntarily move the eyes up or down. The effect is so noticible that PSP is often referred to as the 'can't look up and can't look down' disease. The upper eyelids may also be pulled back, the eyebrows raised, and the brow wrinkled, causing a typical wide-eyed stare.

This can interfere with eating. Patients can't see that they are dropping food when they eat. They may esperience difficulty with descending a flight of stairs, among other things. This problem is not usually as vexing for the patient and family as the inability to maintain eye contact or to coordinate eye movements while reading, but is much easier for the doctor to detect.

Eventually ,patients loose the ability to look up and down at all, and usually about a year later, the ability to look from side-to-side is also lost.

The reduction in the ability to control vertical eye movement is usually the first clue to the doctor that the diagnosis is PSP. The diagnosis is often changed from Parkinson's Disease to PSP at this time.

Other conditions, particularly Parkinson's disease and normal aging, can also sometimes cause difficulty moving the eyes up. However, PSP is nearly unique in also causing problems moving the eyes down.

Because the main difficulty with the eyes is in aiming them properly, reading often becomes difficult or impossible. The patient finds it difficult to shift down to the beginning of the next line automatically after reaching the end of the first line.

This is different from just needing reading glasses. An eye doctor unfamiliar with PSP may be baffled by the patient's complaint of being unable to read a newspaper despite normal ability to read the individual letters on an eye chart.

Another common visual problem is an inability to maintain eye contact during conversation. This can give the mistaken impression that the patient is senile, hostile, or uninterested. The same eye movement problem can create the symptom of "tunnel vision" and can interfere with driving a car.

With PSP reflex or unwilled eye movements remain normal. Thus, when the patient's head is tilted upwards, the eyes move to look down. These reflex movements remain normal until late in the course of the disease.

Other Eye Problems

A different eye problem in PSP can be abnormal eyelid movement - either too much or too little. A few patients experience forceful involuntary closing of the eyes for a few seconds or minutes at a time, called "blepharospasm." Others have difficulty opening the eyes, even though the lids seem to be relaxed, and will try to use the muscles of the forehead, or even the fingers, in an effort to open the eyelids ("apraxia of lid opening"). About 20 percent of patients with PSP, eventually develop one of these problems. Others, on the contrary, have trouble closing the eyes and blink very little. While about 15 to 25 blinks per minute is normal, people with PSP blink, on average, only about 3 or 4 times per minute. This can allow the eyes to become irritated. They often react by producing extra tears, which can itself become annoying.

As it can happen with Multiple Sclerosis and other diseases, PSP causes loss of the myelin sheath (the covering of the nerve cell that speeds nerve impulse conduction) in some nerves and destruction of the entire nerve in other areas.

What Causes PSP?

PSP is caused by (or perhaps causes) damage to nerve cells in a portion of the brain called the "midbrain" These cells are involved in eye-movements and balance. The cause of the degeneration of these cells is unknown.

The damage results in progressive lack of coordination, stiffness of the neck and trunk, eating and breathing problems, balance control, unexpected and uncontrollable falling, difficulties with the ability to control eye movement, slow physical movement, cognitive dysfunction, and difficulty with walking and muscle coordination.

People with PSP also have deposits in brain tissues that resemble the deposits found in Alzheimer's disease. There is atrophy (loss of tissue) in most areas of the brain.

We don't know what causes PSP. That said, there does seem to be risk factors leading to the development of the disease that are similar to the recognized risk factors for other neurological diseases such as Parkinson's and Alzheimer's diseases.

Through considerable observations it has been found that the illness is not caused by any single preventable cause. It is not caused by noxious or toxic substances, is not restricted to a specific geographic or climatic region and is not related to race, occupation, social or economic circumstance or diet. Most people who develop PSP come from families with no history of the disease, so it does not seem to be inherited, except in certain rare instances. It is not passed on to children.

Diagnosis

PSP is a clinical diagnosis, meaning there is no "test" for PSP. It is normally diagnosed by a neurologist who looks at the symptoms and compares them with some source of information intended to narrow the possible choices as much as possible.

Diagnosis is always an "educated" guess and can be incorrect. The diagnosis can also change as symptoms appear or change during the progression of the disease.

Owing to the difficulty previously experienced by doctors in diagnosing PSP, the following diagnostic criteria have recently been produced. PSP is a progressive disorder with supranuclear ophthalmoplegia including down gaze abnormalities and at least 2 or more of the following 5 cardinal features:

Other features which may be present include:

How is PSP Different from Parkinson's Disease?

PSP is often mistaken for Parkinson's disease, which is also associated with stiffness, frequent falls, slurred speech, difficulty swallowing, and decreased spontaneous movement. The facial expression in Parkinson's, however, is blank or mask-like, whereas in PSP it is a grimace and wide-eyed stare. PSP does not normally cause the uncontrolled shaking (tremor) in muscles at rest that is associated with Parkinson's disease. Posture is stooped in Parkinson's disease, but erect in PSP. Speech is of low volume in both diseases, but is more slurred and irregular in rhythm in PSP.

Patients with PSP develop abnormal vertical eye movements. A few other neurological diseases share this symptom so presence of this symptom cannot be used as a guarantee the patient has PSP rather than some other disease. As an example Gaucher's type-III, also causes a progressive supranuclear palsy, but it begins horizontally. Other disorders that may be mistaken for PSP include corticobasal degeneration, Pick's Disease, Multi-system Atrophy (MSA) and Diffuse Lewy Body disease.

When compared with the symptoms of parkinsonism, patients with PSP usually have gait instability, absence of tremor, little or no response to levadopa and dopamine agonists and develop the vision problems normally associated with the disease's progression.

Analysis of protein in the cerebrospinal fluid (CSF) may provide a useful tool in differential diagnosis (i.e. between cortico-basilar degeneration and supranuclear palsy).

Multiple strokes or abnormal accumulations of fluid within the skull (hydrocephalus) can also cause balance problems similar to PSP. Magnetic resonance imaging (MRI) scans of the brain may be needed to rule out these conditions. In advanced cases, MRI shows characteristic abnormalities in the brainstem described as "mouse ears."

Symptoms

Symptoms may include:

Motor/Physical
Vision
Personality/Emotion
Cognitive
Other
More Information Concerning Symptoms
Facial stiffness

The face becomes stiff, immobile and furrowed. Facial and jaw jerks are exaggerated, though more often than not the mouth gapes open, and drooling is common. These symptoms are also signs of pseudobulbar palsy.

Gait and muscles

The head is usually hyperextended and the neck becomes stiff and extended and will resist forward and backward movement, making going up and down stairs difficult. Rigidity and bradykinesia of the limbs develop slowly. The combination of these symptoms (inability to look down, rigidity and stiffness) causes an increasing awkwardness, disturbance of gait and hesitancy. Unsteadiness and falls are common problems (often the first symptoms) and the person can often totter backwards and fall without knowing why. Walking becomes more and more hesitant and awkward as the tendency to fall backwards continues. The cause of this phenomenon is unknown and is often mistaken for the gait disturbance typical of early Parkinson's.

Swallowing problems (Dysphagia)

Swallowing tough foods or thin liquids can become difficult because of throat muscle weakness or incoordination. This tends to occur later than the walking, visual, and speech problems, but can become very troublesome if the patient tends to choke on food. Unlike the other difficulties in PSP, this one can sometimes pose a danger for the patient - the danger of food going down the wrong pipe into the breathing passages, termed "aspiration." Usually, difficulty managing thin liquids precedes difficulty with solid food. This is because in PSP, the swallowing muscles have difficulty creating a watertight seal separating the path to the stomach from the path to the lungs. The same is true for the swallowing difficulty of many neurological diseases. For non-neurologic conditions such as stricture of the esophagus, however, difficulties start with solid foods.

Repeated, minor, often unnoticed episodes of small amounts of food and drink dripping into the lungs can cause pneumonia. Often, it is not apparent to the physician or family that the PSP patient's pneumonia is in fact the result of subtle aspiration. But "aspiration pneumonia," in fact, is the most common cause of death in PSP.

There are speech and swallowing difficulties, with repetitive swallowing of saliva, explosive coughing and heightened palate and throat reflexes.

Common signs that a person is having difficulty swallowing might include:

Mental changes

Mental changes are often limited to personality alteration and forgetfulness. As time goes on however most patients develop a mild or moderate degree of mental impairment or dementia.

In PSP, the dementia, if it does occur, does not feature the memory problem that is so apparent in Alzheimer's disease. Rather, the dementia of PSP is characterized by slowed thought and difficulty combining different ideas into a new idea or plan. These mental functions are performed mostly by the front part of the brain (the "frontal lobes"). In Alzheimer's, on the other hand, the problem is mostly in the part of the brain just above the ears (the "temporal lobes"), where memory functions are concentrated.

Alzheimer's disease also includes either difficulty with language (such as trouble recalling correct names of common objects) or difficulty finding one's way around a previous familiar environment. Fortunately, these symptoms almost never occur in PSP.

Slowing of thought can cause major problems for people with PSP by making it difficult to partake in conversation. A question may be answered with great accuracy and detail, but with a delay of several minutes.

Late stages

In the late stages of PSP, the eyes are fixed centrally, and reflex movement may be totally absent. Bradykinesia is prominent and the person assumes a rigid and double hemiplegic-type posture. That is, the body becomes totally rigid and unable to be moved voluntarily. There is particular difficulty with trunk movements when turning from side to side and sitting up. Because of these symptoms and the inability to control one's movements, the person becomes immobile and bedridden. In extreme cases of poor swallowing a tube may be inserted into the stomach for feeding.

The average length of illness, from diagnosis to death, is 5 to 6 years, with the range being 2 to 11 years. Men seem to be more affected by the disease than women. There are an estimated 20,000 cases in the USA, 6,000 in the UK and up to 1,500 in Australia. Misdiagnosis is frequent and it is most commonly mistaken for Parkinson's, although it is only about 3 per cent as common.

Patient Care and Treatment

PSP cannot presently be cured. A true cure would require the ability to regenerate, restore and renew the brain tissue and neurotransmitter connections destroyed or damaged by the disease. There is hope that future medical progress will lead to the ability to control and slow the presently relentless aggressive progression of the disease and by doing this extend the life of its victims.

People with PSP usually can remain at home with their families during its early stages. As the disease progresses they may require more care than the family can provide and access to a skilled nursing facility may be necessary. Falling is always a danger when the patient is able to still get around physically so their activities require constant close supervision. The patient should be checked often by their medical team to monitor the effects of any treatment and make changes if needed.

Individuals with PSP should remain physically, mentally, and socially active as long as they are able.

A balanced diet that includes plenty of fruits and vegetables will help maintain a healthy weight and prevent malnutrition and constipation.

Medications

Drugs are sometimes given in an attempt to try to relieve or modify the symptoms associated with the disease. None claim to either cure or slow its progression, Thus, treatment with drugs is usually disappointing and expermental.

Remember too that each drug has the capability of causing serious side-effects either immediately or over the long-term which in turn may cause the patient's condition to worsen rather than improve.

Most persons with PSP are resistant to the dopaminergic medications commonly used used to treat in Parkinson's disease, such as levodopa (Sinemet). This may be because these patients usually have more lesions in non-dopaminergic neurotransmitter systems than they have those in the dopaminergic areas of the brain normally affected by Parkinson's disease.

Though limb rigidity, stiffness, slowness of movement and balance may improve somewhat in patients treated with levodopa, the eye movement problem and axial dystonia - both common with PSP - are unaffected.

Anticholinergic medications, such as trihexyphenidyl (Artane), which restore function to neurotransmitters, or tricyclic drugs, such as amitriptyline (Elavil) may improve speech, walking, and inappropriate emotional responses.

It must be remembered though that since it has been found the lack of a neurotransmitter called acetycholine may also contribute to the symptoms of PSP the use of any anticholinergic medication may also tend to worsen symptoms long-term or increase the speed of progression of this disease.

Medication, if provided, needs to be individualised. Doctors should work with the patient and their caregiver to establish a suitable drug regimen. It is a personal choice whether to provide drugs to the patient at all since most seem to have either have adverse side-effects or do not work at all. Remember too that as we age the liver generally works slower and has a greater problem getting drugs out of the body. Thus, a drug dosage that provides no side-effect problems with a younger person may be too large for an older person.

Other Treatments

Surgery - which has been useful to those diagnosed with Parkinson's disease has been tried without success to treat those diagnosed with PSP.

Botulinum toxin can be used to treat eyelid spasms and other types of dystonia that sometimes occur in PSP.

Artificial tears, drops and ointments can help prevent the drying out of the eyes that may occur from decreased blinking. It is important to keep the eyes moist. Failing to do so may cause physical damage to the surface of the eyeball. Ask your medical advisor for product recommendations.

Speech therapy may help manage the swallowing and speech difficulty in PSP. As the disease progresses, the difficulty in swallowing may cause the patient to choke and get small amounts of food in the lungs. This condition can cause aspiration pneumonia. The patient may also lose too much weight. In these cases, a feeding tube may be needed.

Additional Tips on how to Cope with the Disease

The PSP patient may need alternative communication devices, such as pointing boards or computer-based systems. Books on tape provide an alternative when reading is no longer possible.

The home environment should be modified to decrease potential injury from falls. Caregivers can improve the safety of the person with PSP by keeping pathways in the home clear of objects such as toys, floor rugs, or low furniture that are difficult to see without looking down. An occupational therapist can advise on these and other home modifications to improve safety, comfort, and usability of the home environment.

Walkers can be weighted in front, to prevent backward falls and handrails can be installed in the bathroom.

Dry eyes from infrequent blinking can be treated with drops or ointments.

Eating

When the patient is trying to eat:

Walking
Other exercises
Carers and coping strategies

Physiotherapists, occupational therapists, speech pathologists, psychologists and social workers all have important roles in assisting in the management of PSP.

Prognosis

PSP gets progressively worse but is not itself directly life-threatening. The patient's condition gradually deteriorates. After about seven years, balance problems and stiffness make it nearly impossible for the patient to walk. Persons with PSP become more and more immobile and unable to care for themselves. Death is not caused by the PSP itself. It is usually caused by pneumonia related to choking on secretions or by starvation related to swallowing difficulty. It usually occurs within 10 years, but if good general health and nutrition are maintained, the patient may survive longer.

http:// www.pspinformation.com /disease/psp/pspinfo.shtml

Document last modified:01/19/08 06:41:58 PM